Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach:
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg
2016
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046039206 | ||
| 003 | DE-604 | ||
| 005 | 20190724 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190709s2016 gw |||| o||u| ||||||eng d | ||
| 015 | |a 19,O07 |2 dnb | ||
| 016 | 7 | |a 1188467220 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-111631 |2 urn | |
| 035 | |a (OCoLC)1111890155 | ||
| 035 | |a (DE-599)DNB1188467220 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Schöffski, Patrick |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach |c Patrick Schöffski, Agnieszka Wozniak, Oliver Schöffski, Liesbet van Eycken, Maria Debiec-Rychter |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2016 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a Biomarker | ||
| 653 | |a Costs | ||
| 653 | |a Gastrointestinal stromal tumor | ||
| 653 | |a Tyrosine kinase | ||
| 653 | |a Kit | ||
| 653 | |a Platelet-derived growth factor receptor alpha | ||
| 653 | |a Mutational analysis | ||
| 653 | |a Imatinib | ||
| 653 | |a Sunitinib | ||
| 653 | |a Regorafenib | ||
| 700 | 1 | |a Wozniak, Agnieszka |e Verfasser |4 aut | |
| 700 | 1 | |a Schöffski, Oliver |e Verfasser |4 aut | |
| 700 | 1 | |a Eycken, Liesbet van |e Verfasser |4 aut | |
| 700 | 1 | |a Debiec-Rychter, Maria |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Oncology Research and Treatment |g 39 (2016), Seite 811-816 |o 10.1159/000453057 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-111631 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1188467220/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/11163 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031420934 | ||
| 347 | |b PDF | ||
Datensatz im Suchindex
| _version_ | 1804180296382283776 |
|---|---|
| any_adam_object | |
| author | Schöffski, Patrick Wozniak, Agnieszka Schöffski, Oliver Eycken, Liesbet van Debiec-Rychter, Maria |
| author_facet | Schöffski, Patrick Wozniak, Agnieszka Schöffski, Oliver Eycken, Liesbet van Debiec-Rychter, Maria |
| author_role | aut aut aut aut aut |
| author_sort | Schöffski, Patrick |
| author_variant | p s ps a w aw o s os l v e lv lve m d r mdr |
| building | Verbundindex |
| bvnumber | BV046039206 |
| collection | ebook |
| ctrlnum | (OCoLC)1111890155 (DE-599)DNB1188467220 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02273nmm a2200565zc 4500</leader><controlfield tag="001">BV046039206</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190724 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190709s2016 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,O07</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1188467220</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-111631</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1111890155</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1188467220</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schöffski, Patrick</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach</subfield><subfield code="c">Patrick Schöffski, Agnieszka Wozniak, Oliver Schöffski, Liesbet van Eycken, Maria Debiec-Rychter</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Costs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gastrointestinal stromal tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Tyrosine kinase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Kit</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Platelet-derived growth factor receptor alpha</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mutational analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Imatinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sunitinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Regorafenib</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wozniak, Agnieszka</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schöffski, Oliver</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eycken, Liesbet van</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Debiec-Rychter, Maria</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Oncology Research and Treatment</subfield><subfield code="g">39 (2016), Seite 811-816</subfield><subfield code="o">10.1159/000453057</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-111631</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1188467220/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/11163</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031420934</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="b">PDF</subfield></datafield></record></collection> |
| id | DE-604.BV046039206 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:33:30Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031420934 |
| oclc_num | 1111890155 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Schöffski, Patrick Verfasser aut Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach Patrick Schöffski, Agnieszka Wozniak, Oliver Schöffski, Liesbet van Eycken, Maria Debiec-Rychter Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2016 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager Biomarker Costs Gastrointestinal stromal tumor Tyrosine kinase Kit Platelet-derived growth factor receptor alpha Mutational analysis Imatinib Sunitinib Regorafenib Wozniak, Agnieszka Verfasser aut Schöffski, Oliver Verfasser aut Eycken, Liesbet van Verfasser aut Debiec-Rychter, Maria Verfasser aut Sonderdruck aus Oncology Research and Treatment 39 (2016), Seite 811-816 10.1159/000453057 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-111631 Resolving-System kostenfrei Volltext http://d-nb.info/1188467220/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/11163 Verlag kostenfrei Volltext |
| spellingShingle | Schöffski, Patrick Wozniak, Agnieszka Schöffski, Oliver Eycken, Liesbet van Debiec-Rychter, Maria Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach |
| title | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach |
| title_auth | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach |
| title_exact_search | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach |
| title_full | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach Patrick Schöffski, Agnieszka Wozniak, Oliver Schöffski, Liesbet van Eycken, Maria Debiec-Rychter |
| title_fullStr | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach Patrick Schöffski, Agnieszka Wozniak, Oliver Schöffski, Liesbet van Eycken, Maria Debiec-Rychter |
| title_full_unstemmed | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach Patrick Schöffski, Agnieszka Wozniak, Oliver Schöffski, Liesbet van Eycken, Maria Debiec-Rychter |
| title_short | Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach |
| title_sort | overcoming cost implications of mutational analysis in patients with gastrointestinal stromal tumors a pragmatic approach |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-111631 http://d-nb.info/1188467220/34 https://open.fau.de/handle/openfau/11163 |
| work_keys_str_mv | AT schoffskipatrick overcomingcostimplicationsofmutationalanalysisinpatientswithgastrointestinalstromaltumorsapragmaticapproach AT wozniakagnieszka overcomingcostimplicationsofmutationalanalysisinpatientswithgastrointestinalstromaltumorsapragmaticapproach AT schoffskioliver overcomingcostimplicationsofmutationalanalysisinpatientswithgastrointestinalstromaltumorsapragmaticapproach AT eyckenliesbetvan overcomingcostimplicationsofmutationalanalysisinpatientswithgastrointestinalstromaltumorsapragmaticapproach AT debiecrychtermaria overcomingcostimplicationsofmutationalanalysisinpatientswithgastrointestinalstromaltumorsapragmaticapproach |